C. Chow

发表

Age-dependent incidence, time course, and consequences of thymic renewal in adults.

C. Mackall, E. Jones, R. Gress, 2005, The Journal of clinical investigation.

Mammographic density does not differ between unaffected BRCA1/2 mutation carriers and women at low-to-average risk of breast cancer

Mitchell H. Gail, Claudia Giambartolomei, Gretchen L. Gierach, 2010, Breast Cancer Research and Treatment.

Combination targeted therapy with sorafenib and bevacizumab results in enhanced toxicity and antitumor activity.

Lori Minasian, Liang Cao, Christina M. Annunziata, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Progressive preclinical interstitial lung disease in rheumatoid arthritis.

W. Travis, M. Stylianou, I. Rosas, 2008, Archives of internal medicine.

Phase I/II study of 72-hour infusional paclitaxel and doxorubicin with granulocyte colony-stimulating factor in patients with metastatic breast cancer.

F. Ognibene, D. Venzon, K. Cowan, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A Pilot Study of Dose Intense Doxorubicin and Cyclophosphamide Followed by Infusional Paclitaxel in High-Risk Primary Breast Cancer

D. Venzon, K. Cowan, J. O’Shaughnessy, 2003, Breast Cancer Research and Treatment.

Engraftment of MDR1 and NeoR gene-transduced hematopoietic cells after breast cancer chemotherapy.

I. Pastan, M. Gottesman, D. Venzon, 1999, Blood.

Lack of reliability of CA125 response criteria with anti‐VEGF molecularly targeted therapy

S. Steinberg, E. Kohn, L. Minasian, 2008, Cancer.

Administration of rhIL-7 in humans increases in vivo TCR repertoire diversity by preferential expansion of naive T cell subsets

D. Venzon, R. Amato, T. Fry, 2008, The Journal of experimental medicine.

Early interstitial lung disease in familial pulmonary fibrosis.

W. Travis, D. Nguyen, I. Rosas, 2007, American journal of respiratory and critical care medicine.

Preliminary results for positron emission mammography: real-time functional breast imaging in a conventional mammography gantry

J. Mulshine, I. Weinberg, E. Jones, 1996, European Journal of Nuclear Medicine.

Diagnostic accuracy of laparoscopy, magnetic resonance imaging, and histopathologic examination for the detection of endometriosis.

M. Merino, L. Nieman, P. Stratton, 2003, Fertility and sterility.

Pilot trial of the safety, tolerability, and retinoid levels of N-(4-hydroxyphenyl) retinamide in combination with tamoxifen in patients at high risk for developing invasive breast cancer.

M. Kaiser-Kupfer, M. Merino, D. Venzon, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase I clinical trial of costimulated, IL-4 polarized donor CD4+ T cells as augmentation of allogeneic hematopoietic cell transplantation.

S. Steinberg, B. Levine, C. June, 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Mammographic density does not differ between unaffectedBRCA1/2mutation carriers and women at low-to-average risk of breast cancer.

M. Gail, M. Greene, G. Gierach, 2009 .

Imaging in inflammatory breast carcinoma.

C. Chow, 2005, Breast disease.

Lipoatrophic-lipodystrophic syndromes: the spectrum of findings on MR imaging.

Simeon I. Taylor, S. Taylor, C. Chow, 2002, AJR. American journal of roentgenology.

Age-dependent incidence, time course, and consequences of thymic renewal in adults

C. Mackall, E. Jones, R. Gress, 2005 .

Keratinocyte growth factor augments immune reconstitution after autologous hematopoietic progenitor cell transplantation in rhesus macaques.

K. Camphausen, S. Pittaluga, M. Meier-Schellersheim, 2007, Blood.

Phase I Study of Recombinant Human Interleukin-7 Administration in Subjects with Refractory Malignancy

S. Steinberg, M. Stetler-Stevenson, R. Amato, 2010, Clinical Cancer Research.

Phase I clinical trial of alitretinoin and tamoxifen in breast cancer patients: toxicity, pharmacokinetic, and biomarker evaluations.

M. Merino, D. Venzon, D. Kleiner, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase I C linical T rial o f A litretinoin a nd T amoxifen i n Breast C ancer P atients: T oxicity, P harmacokinetic, a nd Biomarker E valuations

M. Merino, D. Venzon, D. Kleiner, 2001 .

Phase I study of high-dose piroxantrone with granulocyte colony-stimulating factor.

G. Otterson, F. Balis, J. O’Shaughnessy, 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A pilot study to evaluate the vascular endothelial growth factor receptor tyrosine kinase inhibitor AZD2171 and chemotherapy in locally advanced and inflammatory breast cancer.

S. Swain, A. Tan, Sherry X. Yang, 2005, Clinical breast cancer.

A phase I study of sequential versus concurrent interleukin-3 and granulocyte-macrophage colony-stimulating factor in advanced breast cancer patients treated with FLAC (5-fluorouracil, leucovorin, doxorubicin, cyclophosphamide) chemotherapy

A. Tolcher, D. Venzon, P. Keegan, 1995 .

A. Tolcher, D. Venzon, P. Keegan, 1995, Blood.

Phase II Clinical Experience with Dose-Adjusted EPOCH-Fludarabine, a Novel Regimen for Targeted Immune Depletion (TID) and Disease Control in Patients with Lymphoid Malignancies Prior to Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation (RIST).

W. Wilson, S. Steinberg, M. Bishop, 2006 .

Effect of Raloxifene on Mammographic Density and Breast Magnetic Resonance Imaging in Premenopausal Women at Increased Risk for Breast Cancer

Sheila Prindiville, Claudia E. Galbo, D. Venzon, 2008, Cancer Epidemiology Biomarkers & Prevention.

Phase I Trial of the Cyclin-Dependent Kinase Inhibitor Flavopiridol in Combination with Docetaxel in Patients with Metastatic Breast Cancer

S. Steinberg, S. Swain, A. Tan, 2004, Clinical Cancer Research.

Naı¨ve T-Cell Dynamics in Human Immunodeﬁciency Virus Type 1 Infection: Effects of Highly Active Antiretroviral Therapy Provide Insights into the Mechanisms of Naı¨ve T-Cell Depletion

R. Lempicki, D. Dimitrov, C. Yoder, 2006 .

Positron emission tomography for lymphoma staging: tissue remains the issue.

R. Srinivasan, D. Schrump, R. Childs, 2005, Journal of the National Cancer Institute.

A phase I trial and pharmacokinetic study of tipifarnib, a farnesyltransferase inhibitor, and tamoxifen in metastatic breast cancer.

D. Venzon, F. Balis, B. Widemann, 2005, Clinical cancer research : an official journal of the American Association for Cancer Research.

Paclitaxel chemotherapy after autologous stem-cell transplantation and engraftment of hematopoietic cells transduced with a retrovirus containing the multidrug resistance complementary DNA (MDR1) in metastatic breast cancer patients.

W. Wilson, S. Steinberg, I. Pastan, 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

Metastatic melanoma: Correlation of MRI characteristics and histopathology

F. Marincola, J. Taubenberger, D. Venzon, 1996, Journal of magnetic resonance imaging : JMRI.

Allogeneic lymphocytes induce tumor regression of advanced metastatic breast cancer.

S. Steinberg, M. Bishop, J. Gea-Banacloche, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Relationships between computer-extracted mammographic texture pattern features and BRCA1/2mutation status: a cross-sectional study

Hui Li, Li Lan, Claudia Giambartolomei, 2014, Breast Cancer Research.

Phase II trial of ixabepilone, an epothilone B analog, given daily for three days every three weeks, in metastatic breast cancer

S. Steinberg, S. Swain, James J. Lee, 2006, Investigational New Drugs.

Phase II trial of ixabepilone, an epothilone B analog, in patients with metastatic breast cancer previously untreated with taxanes.

S. Steinberg, S. Swain, Sherry X. Yang, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Evaluation of biologic end points and pharmacokinetics in patients with metastatic breast cancer after treatment with erlotinib, an epidermal growth factor receptor tyrosine kinase inhibitor.

S. Steinberg, S. Hewitt, S. Swain, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Mammography of lymphatic filariasis.

J. McCarthy, T. Nutman, C. Chow, 1996, AJR. American journal of roentgenology.

Antiangiogenic and antitumor effects of bevacizumab in patients with inflammatory and locally advanced breast cancer.

Kevin Camphausen, Mark Sherman, Peter Choyke, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Efficacy of reduced-intensity allogeneic stem cell transplantation in chemotherapy-refractory non-hodgkin lymphoma.

W. Wilson, S. Steinberg, M. Bishop, 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Establishing a platform for immunotherapy: clinical outcome and study of immune reconstitution after high-dose chemotherapy with progenitor cell support in breast cancer patients.

S. Steinberg, M. Bishop, S. Kummar, 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Preoperative FLAC/Granulocyte-Colony-Stimulating Factor Chemotherapy for Stage II Breast Cancer: A Prospective Randomized Trial

S. Steinberg, R. Altemus, M. Merino, 2003, Annals of Surgical Oncology.

Effect of tamoxifen on mammographic density.

D. Venzon, J. O’Shaughnessy, J. Zujewski, 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Clinical evidence of a graft-versus-lymphoma effect against relapsed diffuse large B-cell lymphoma after allogeneic hematopoietic stem-cell transplantation.

S. Steinberg, S. Pittaluga, M. Bishop, 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

Phase I and pharmacokinetic study of farnesyl protein transferase inhibitor R115777 in advanced cancer.

C. Bowden, R. Nussenblatt, K. Cowan, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Naïve T-Cell Dynamics in Human Immunodeficiency Virus Type 1 Infection: Effects of Highly Active Antiretroviral Therapy Provide Insights into the Mechanisms of Naïve T-Cell Depletion

Julia A. Metcalf, Irini Sereti, Christian Yoder, 2006, Journal of Virology.

Relationships between computer-extracted mammographic texture pattern features and BRCA1/2mutation status: a cross-sectional study

Hui Li, Li Lan, Claudia Giambartolomei, 2014, Breast Cancer Research.

Lipoatrophic-Lipodystrophic Syndromes: The Spectrum

Simeon I. Taylor, C. Chow, A. Premkumar, 2002 .

Increases in CD4+ T Lymphocytes Occur Without Increases in Thymic Size in HIV‐Infected Subjects Receiving Interleukin‐2 Therapy

J. Metcalf, K. Miller, J. Kovacs, 2003, Journal of acquired immune deficiency syndromes.

Phase II clinical trial of ixabepilone in metastatic breast cancer (MBC) patients previously untreated with taxanes.

S. Steinberg, J. Lee, S. Swain, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Selection of local therapy after neoadjuvant chemotherapy in patients with stage IIIA,B breast cancer

P. Okunieff, S. Steinberg, K. Cowan, 1998, Annals of Surgical Oncology.

Automated quantification of high-resolution CT scan findings in individuals at risk for pulmonary fibrosis.

Jianhua Yao, W. Gahl, I. Rosas, 2011, Chest.

Effect of raloxifene on bone mineral density in premenopausal women at increased risk of breast cancer.

D. Venzon, D. Danforth, J. Zujewski, 2006, The Journal of clinical endocrinology and metabolism.

A Phase II Trial of Neoadjuvant Docetaxel and Capecitabine for Locally Advanced Breast Cancer

M. Merino, D. Venzon, S. Swain, 2004, Clinical Cancer Research.

Cardiac Toxicity and Efficacy of Trastuzumab Combined with Pertuzumab in Patients with Trastuzumab-Insensitive Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer

S. Steinberg, S. Swain, Sherry X. Yang, 2008, Clinical Cancer Research.

CardiacToxicity and Efficacy of Trastuzumab Combined with Pertuzumab in Patients with Trastuzumab-Insensitive Human Epidermal Growth Factor Receptor 2^ Positive Metastatic Breast Cancer

S. Steinberg, S. Swain, Sherry X. Yang, 2008 .

Inflammatory breast cancer: dynamic contrast-enhanced MR in patients receiving bevacizumab--initial experience.

S. Steinberg, P. Choyke, Sandeep N. Gupta, 2007, Radiology.

Magnetic resonance imaging of the forearm as a diagnostic aid in patients with sporadic inclusion body myositis

M. Dalakas, C. Chow, E A Sekul, 1997, Neurology.

DCE-MRI Segmentation and Motion Correction Based on Active Contour Model and Forward Mapping

Chao Lu, Jianhua Yao, Sheila Prindiville, 2006, Seventh ACIS International Conference on Software Engineering, Artificial Intelligence, Networking, and Parallel/Distributed Computing (SNPD'06).

MRI of angiolipoma of the breast in Turner's syndrome.

M. Merino, C. Bondy, C. Chow, 2004, AJR. American journal of roentgenology.

Metastatic Melanoma: Correlation of

F. Marincola, J. Taubenberger, C. Chow, 1996 .

Cardiotoxicity after doxorubicin and AZD2171, an oral vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitor, in patients (pts) with breast cancer

S. Swain, C. Chow, D. Rosing, 2007 .

A phase I trial of tipifarnib, a farnesyltransferase inhibitor, and tamoxifen in hormone-receptor positive metastatic breast cancer.

M. Merino, F. Balis, B. Widemann, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Breast Tumor Analysis in Dynamic Contrast Enhanced MRI Using Texture Features and Wavelet Transform

Jianhua Yao, Jeremy Chen, Catherine Chow, 2009, IEEE Journal of Selected Topics in Signal Processing.